» Articles » PMID: 31961797

Lymph Node Characteristics of 6279 N1 Differentiated Thyroid Cancer Patients

Overview
Journal Endocr Connect
Specialty Endocrinology
Date 2020 Jan 22
PMID 31961797
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study examined the clinicopathological characteristics of 6279 N1 differentiated thyroid cancer (DTC) patients who underwent operations in our center.

Methods: This was a retrospective longitudinal analysis. We categorized the DTC on the basis of various lymph node (LN) characteristics. Logistic regression models and multiple linear regression models were used for the correlation analysis.

Results: A total of 3693 (58.8%) N1a patients and 2586 (41.1%) N1b patients were included. Patients with N1b disease had larger metastatic foci (0.5 vs. 0.15 cm), a greater number of metastatic LNs (5 vs. 2), a greater number of dissected LNs (25 vs. 7), and a smaller lymph node ratio (NR, number of positive LNs / number of sampled LNs) (23.1% vs. 28.6%) than patients in stage N1a. Comparing the clinicopathological features, we found that male, increased tumor size, multifocality, and thyroiditis increased the risk of stage N1b disease (P<0.05). Sex, multifocality, capsular infiltration, and tumor size were associated with the size of the metastatic LNs (P<0.05). Sex, capsular infiltration, and nodular goiter were associated with the NR (P<0.05). Male sex, tumor located in inferior lobe, maximal tumor diameter (MTD) <1cm, and nodular goiter were independent predictors for skip metastases (P<0.05). MTD <1cm, central neck metastasis and advanced age were independent predictors for bilateral lateral neck metastasis (BLNM) (P<0.05).

Conclusion: The LN characteristics of stage N1a and N1b disease were associated with significantly different features, such as sex, tumor size, multifocality, capsular infiltration, and nodular goiter.

Citing Articles

The relationship between lateral cervical lymph node positivity rate and recurrence after comprehensive treatment in differentiated thyroid carcinoma: a single-center retrospective cohort study from China.

Ye T, Shao S, Yao S, Wang R Front Oncol. 2025; 15:1484002.

PMID: 40027128 PMC: 11868813. DOI: 10.3389/fonc.2025.1484002.


Evaluating the efficacy of the endoscopic thyroidectomy via sternocleidomastoid muscle posteroinferior approach in identifying occult lateral cervical lymph node metastasis.

Jing Y, Zhou J, Qi X, Wu J, Liu H, Huang J Gland Surg. 2024; 13(11):1986-1995.

PMID: 39678413 PMC: 11635581. DOI: 10.21037/gs-24-340.


PTC located in the upper pole is more prone to lateral lymph node metastasis and skip metastasis.

Dou Y, Hu D, Chen Y, Xiong W, Xiao Q, Su X World J Surg Oncol. 2020; 18(1):188.

PMID: 32723382 PMC: 7389816. DOI: 10.1186/s12957-020-01965-x.

References
1.
Randolph G, Duh Q, Heller K, LiVolsi V, Mandel S, Steward D . The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid. 2012; 22(11):1144-52. DOI: 10.1089/thy.2012.0043. View

2.
Jin W, Jin Y, Ye D, Zheng Z, Sun Y, Zhou X . Predictive Factors of Skip Metastasis in Papillary Thyroid Cancer. Med Sci Monit. 2018; 24:2744-2749. PMC: 5952804. DOI: 10.12659/MSM.907357. View

3.
Nishida T, Katayama S, Tsujimoto M . The clinicopathological significance of histologic vascular invasion in differentiated thyroid carcinoma. Am J Surg. 2002; 183(1):80-6. DOI: 10.1016/s0002-9610(01)00843-1. View

4.
Kim M, Jeon M, Oh H, Park S, Song D, Sung T . Prognostic Implication of N1b Classification in the Eighth Edition of the Tumor-Node-Metastasis Staging System of Differentiated Thyroid Cancer. Thyroid. 2018; 28(4):496-503. DOI: 10.1089/thy.2017.0473. View

5.
Schneider D, Chen H, Sippel R . Impact of lymph node ratio on survival in papillary thyroid cancer. Ann Surg Oncol. 2012; 20(6):1906-11. PMC: 3609925. DOI: 10.1245/s10434-012-2802-8. View